SWIG
VVOS icon

Strategic Wealth Investment Group’s Vivos Therapeutics VVOS Stock Holding History

Strategic Wealth Investment Group’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$310K – 130
2025
Q3 		$310K Buy
+100,000
New +$453K 0.03% 104
2025
Q1 		– Sell
-100,000
Closed -$429K – 125
2024
Q4 		$429K Hold
100,000
– – 0.05% 99
2024
Q3 		$252K Sell
100,000
-28,789
-22% -$75.4K 0.03% 118
2024
Q2 		$304K Buy
+128,789
New +$314K 0.04% 105
2023
Q4 		$1.6M Buy
128,789
+1
+0% +$9 0.24% 53
2023
Q3 		$619K Hold
128,788
– – 0.11% 63
2023
Q2 		$1.64M Hold
128,788
– – 0.26% 62
2023
Q1 		$1.1M Buy
+128,788
New +$2.82M 0.2% 67

Other funds holding VVOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AWA
Acorn Wealth Advisors Grand Blanc, Michigan $410M AUM 21.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Strategic Wealth Investment Group's VVOS Position: Q4 2025 in Review

Strategic Wealth Investment Group sold out of Vivos Therapeutics (VVOS) in Q4 2025, closing a stake of 100,000 shares — an estimated $310K sold.

Strategic Wealth Investment Group first reported a position in VVOS in Q1 2023 and held it in 8 quarters. The position peaked at $1.64M in Q2 2023. 19 funds tracked by Wall St. Rank hold VVOS as of Q4 2025.

  • Strategic Wealth Investment Group reported no remaining Vivos Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Strategic Wealth Investment Group sold 100,000 Vivos Therapeutics shares in Q4 2025, an estimated $310K.
  • Strategic Wealth Investment Group first reported a position in Vivos Therapeutics in Q1 2023 and held it in 8 quarters.
  • Strategic Wealth Investment Group's Vivos Therapeutics position peaked at $1.64M in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q4 2025.

Based on Strategic Wealth Investment Group's 13F filing for Q4 2025, filed 11 Feb 2026.